Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy

Background: Radical cystectomy (RC) carries a high complication rate, including post-operative ileus. Alvimopan is an FDA approved peripherally acting μ-opioid receptor antagonist that has shown favorable results for improved recovery of gastro-intestinal function resulting in decreased hospital len...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Zach, Parker, Will, Griffin, Josh, Isaacson, Tanner, Mirza, Moben, Wyre, Hadley, Holzbeierlein, Jeffrey, Lee, Eugene K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929338/
https://www.ncbi.nlm.nih.gov/pubmed/27398398
http://dx.doi.org/10.3233/BLC-150017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929338/
https://www.ncbi.nlm.nih.gov/pubmed/27398398
http://dx.doi.org/10.3233/BLC-150017

Ejemplares similares